How many studies have been conducted on Homoharringtonine?

BiohacksAI has indexed 300 PubMed studies on Homoharringtonine, including 3 randomized controlled trials (RCTs). 45% of studies involve human subjects.

What are the main research areas for Homoharringtonine?

The primary research domains for Homoharringtonine are 🔬 Oncology, 😴 Sleep, 🛡️ Immunity. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

Homoharringtonine

a protein synthesis inhibitor and induces APOPTOSIS in tumor cells. It is used in the treatment of MYELOID LEUKEMIA, CHRONIC.

300+ PubMed studies analyzed · 3 RCTs · Evidence Score: 45

Research Domains

Homoharringtonine has been studied across 13 research domains including 🔬 Oncology, 😴 Sleep, 🛡️ Immunity, 🏋️ Muscle & Hypertrophy, ⚡ Energy & Fatigue. The primary research focus is 🔬 Oncology with 52% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Homoharringtonine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one

Loading evidence profile...

This evidence profile for Homoharringtonine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.